<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39364016</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>GWAS and polygenic risk score of severe COVID-19 in Eastern Europe.</ArticleTitle><Pagination><StartPage>1409714</StartPage><MedlinePgn>1409714</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1409714</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1409714</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">COVID-19 disease has infected more than 772 million people, leading to 7 million deaths. Although the severe course of COVID-19 can be prevented using appropriate treatments, effective interventions require a thorough research of the genetic factors involved in its pathogenesis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We conducted a genome-wide association study (GWAS) on 7,124 individuals (comprising 6,400 controls who had mild to moderate COVID-19 and 724 cases with severe COVID-19). The inclusion criteria were acute respiratory distress syndrome (ARDS), acute respiratory failure (ARF) requiring respiratory support, or CT scans indicative of severe COVID-19 infection without any competing diseases. We also developed a polygenic risk score (PRS) model to identify individuals at high risk.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We identified two genome-wide significant loci (<i>P</i>-value &lt;5 × 10<sup>-8</sup>) and one locus with approximately genome-wide significance (<i>P</i>-value = 5.92 × 10<sup>-8</sup>-6.15 × 10<sup>-8</sup>). The most genome-wide significant variants were located in the <i>leucine zipper transcription factor like 1</i> (<i>LZTFL1</i>) gene, which has been highlighted in several previous GWAS studies. Our PRS model results indicated that individuals in the top 10% group of the PRS had twice the risk of severe course of the disease compared to those at median risk [odds ratio = 2.18 (1.66, 2.86), <i>P</i>-value = 8.9 × 10<sup>-9</sup>].</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We conducted one of the largest studies to date on the genetics of severe COVID-19 in an Eastern European cohort. Our results are consistent with previous research and will guide further epidemiologic studies on host genetics, as well as for the development of targeted treatments.</AbstractText><CopyrightInformation>Copyright © 2024 Kovalenko, Shaheen, Vergasova, Kamelin, Rubinova, Kharitonov, Kim, Plotnikov, Elmuratov, Borovkova, Storozheva, Solonin, Gilyazova, Mironov, Khusnutdinova, Petrikov, Ilinskaya, Ilinsky and Rakitko.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kovalenko</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaheen</LastName><ForeName>Layal</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergasova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamelin</LastName><ForeName>Alexey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubinova</LastName><ForeName>Valerya</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kharitonov</LastName><ForeName>Dmitry</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plotnikov</LastName><ForeName>Nikolay</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmuratov</LastName><ForeName>Artem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genetic Technologies Ltd., Yerevan, Armenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borovkova</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storozheva</LastName><ForeName>Maya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solonin</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilyazova</LastName><ForeName>Irina</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Genetics, Ufa Federal Research Centre, Russian Academy of Sciences, Ufa, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bashkir State Medical University, Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mironov</LastName><ForeName>Petr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bashkir State Medical University, Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khusnutdinova</LastName><ForeName>Elza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry and Genetics, Ufa Federal Research Centre, Russian Academy of Sciences, Ufa, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bashkir State Medical University, Ufa, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrikov</LastName><ForeName>Sergey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilinskaya</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Eligens SIA, Mārupe, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilinsky</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Eligens SIA, Mārupe, Latvia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rakitko</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Genotek Ltd., Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Bioinformatics, Faculty of Computer Science, HSE University, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">GWAS</Keyword><Keyword MajorTopicYN="N">LZTFL1 gene</Keyword><Keyword MajorTopicYN="N">polygenic risk score</Keyword><Keyword MajorTopicYN="N">severe COVID-19</Keyword></KeywordList><CoiStatement>EKo, LS, EV, AKa, VR, DK, AKi, NP, and AR were employed by Genotek Ltd. AE was employed by Genetic Technologies Ltd. AI and VI were employed by Eligens SIA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>11</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39364016</ArticleId><ArticleId IdType="pmc">PMC11446758</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1409714</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO coronavirus (COVID-19) dashboard. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available at: https://covid19.who.int/ (accessed November 30, 2023).</Citation></Reference><Reference><Citation>Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al. . Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis. PLoS ONE. (2021) 16:e0247461. 10.1371/journal.pone.0247461</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Wang Z, Liao H, Marley G, Wu D, Tang W, et al. . Epidemiologic, clinical, and laboratory findings of the COVID-19 in the current pandemic: systematic review and meta-analysis. BMC Infect Dis. (2020) 20:640. 10.1186/s12879-020-05371-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05371-2</ArticleId><ArticleId IdType="pmc">PMC7457225</ArticleId><ArticleId IdType="pubmed">32867706</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. . Risk factors of critical and mortal COVID-19 cases: a systematic literature review and meta-analysis. J Infect. (2020) 81:e16–25. 10.1016/j.jinf.2020.04.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7177098</ArticleId><ArticleId IdType="pubmed">32335169</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova JL, Su HC, COVID Human Genetic Effort. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. (2020) 181:1194–9. 10.1016/j.cell.2020.05.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.016</ArticleId><ArticleId IdType="pmc">PMC7218368</ArticleId><ArticleId IdType="pubmed">32405102</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. (2023) 29:334–43. 10.1038/s41591-022-02156-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02156-9</ArticleId><ArticleId IdType="pubmed">36797482</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Nalla LV, Sharma M, Sharma N, Singh AA, Malim FM, et al. . Association of COVID-19 with comorbidities: an update. ACS Pharmacol Transl Sci. (2023) 6:334–54. 10.1021/acsptsci.2c00181</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsptsci.2c00181</ArticleId><ArticleId IdType="pmc">PMC10000013</ArticleId><ArticleId IdType="pubmed">36923110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng WH. Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis. MBio. (2021). 10.1128/mBio.03647-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03647-20</ArticleId><ArticleId IdType="pmc">PMC7885108</ArticleId><ArticleId IdType="pubmed">33563817</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. . Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. (2020) 369:m1966. 10.1136/bmj.m1966</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. . Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. (2020) 323:1574–81. 10.1001/jama.2020.5394</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.5394</ArticleId><ArticleId IdType="pmc">PMC7136855</ArticleId><ArticleId IdType="pubmed">32250385</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19. Nature. (2021) 600:472–7. 10.1038/s41586-021-03767-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03767-x</ArticleId><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative. A first update on mapping the human genetic architecture of COVID-19. Nature. (2022) 608:E1–10. 10.1038/s41586-022-04826-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04826-7</ArticleId><ArticleId IdType="pmc">PMC9352569</ArticleId><ArticleId IdType="pubmed">35922517</ArticleId></ArticleIdList></Reference><Reference><Citation>Horowitz JE, Kosmicki JA, Damask A, Sharma D, Roberts GHL, Justice AE, et al. . Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nat Genet. (2022) 54:382–92. 10.1038/s41588-021-01006-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-01006-7</ArticleId><ArticleId IdType="pmc">PMC9005345</ArticleId><ArticleId IdType="pubmed">35241825</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishak A, Mehendale M, AlRawashdeh MM, Sestacovschi C, Sharath M, Pandav K, et al. . The association of COVID-19 severity and susceptibility and genetic risk factors: a systematic review of the literature. Gene. (2022) 836:146674. 10.1016/j.gene.2022.146674</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2022.146674</ArticleId><ArticleId IdType="pmc">PMC9195407</ArticleId><ArticleId IdType="pubmed">35714803</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ke Y, Xia X, Wang Y, Cheng F, Liu X, et al. . Genome-wide association study of COVID-19 severity among the Chinese population. Cell Discov. (2021) 7:1–16. 10.1038/s41421-021-00318-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00318-6</ArticleId><ArticleId IdType="pmc">PMC8408196</ArticleId><ArticleId IdType="pubmed">34465742</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, et al. . Host genetic factors determining COVID-19 susceptibility and severity. eBioMedicine. (2021) 72:103629. 10.1016/j.ebiom.2021.103629</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103629</ArticleId><ArticleId IdType="pmc">PMC8512556</ArticleId><ArticleId IdType="pubmed">34655949</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner J, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, Müller M, et al. . Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01. EClinicalMedicine. (2021) 40:101099. 10.1016/j.eclinm.2021.101099</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101099</ArticleId><ArticleId IdType="pmc">PMC8410317</ArticleId><ArticleId IdType="pubmed">34490415</ArticleId></ArticleIdList></Reference><Reference><Citation>Farooqi R, Kooner JS, Zhang W. Associations between polygenic risk score and covid-19 susceptibility and severity across ethnic groups: UK Biobank analysis. BMC Med Genomics. (2023) 16:1–15. 10.1186/s12920-023-01584-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-023-01584-x</ArticleId><ArticleId IdType="pmc">PMC10311902</ArticleId><ArticleId IdType="pubmed">37386504</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossfield SSR, Chaddock NJM, Iles MM, Pujades-Rodriguez M, Morgan AW. Interplay between demographic, clinical and polygenic risk factors for severe COVID-19. Int J Epidemiol. (2022) 51:1384–95. 10.1093/ije/dyac137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac137</ArticleId><ArticleId IdType="pmc">PMC9278202</ArticleId><ArticleId IdType="pubmed">35770811</ArticleId></ArticleIdList></Reference><Reference><Citation>Nostaeva AV, Shimansky VS, Apalko SV, Kuznetsov IA, Sushentseva NN, Popov OS, et al. . Analysis of associations between polygenic risk score and COVID-19 severity in russian population using low-pass genome sequencing. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory. 10.1101/2023.11.20.23298335</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.11.20.23298335</ArticleId></ArticleIdList></Reference><Reference><Citation>Katki HA, Berndt SI, Machiela MJ, Stewart DR, Garcia-Closas M, Kim J, et al. . Increase in power by obtaining 10 or more controls per case when type-1 error is small in large-scale association studies. BMC Med Res Methodol. (2023) 23:153. 10.1186/s12874-023-01973-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-023-01973-x</ArticleId><ArticleId IdType="pmc">PMC10308790</ArticleId><ArticleId IdType="pubmed">37386403</ArticleId></ArticleIdList></Reference><Reference><Citation>Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. (2007) 81:1084–97. 10.1086/521987</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521987</ArticleId><ArticleId IdType="pmc">PMC2265661</ArticleId><ArticleId IdType="pubmed">17924348</ArticleId></ArticleIdList></Reference><Reference><Citation>1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM. A global reference for human genetic variation. Nature. (2015) 526:68–74. 10.1038/nature15393</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15393</ArticleId><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood AR, Teumer A, et al. . A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. (2016) 48:1279–83. 10.1038/ng.3643</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3643</ArticleId><ArticleId IdType="pmc">PMC5388176</ArticleId><ArticleId IdType="pubmed">27548312</ArticleId></ArticleIdList></Reference><Reference><Citation>Staples J Qiao D Cho MH Silverman EK University University of Washington Center for Mendelian Genomics Nickerson DA . PRIMUS: rapid reconstruction of pedigrees from genome-wide estimates of identity by descent. Ame J Hum Genet. (2014) 95:553–64. 10.1016/j.ajhg.2014.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2014.10.005</ArticleId><ArticleId IdType="pmc">PMC4225580</ArticleId><ArticleId IdType="pubmed">25439724</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahsler M, Piekenbrock M, Doran D. dbscan: fast density-based clustering with R. J Stat Softw. (2019) 91:1–30. 10.18637/jss.v091.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v091.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Host Genetics Initiative. Available at: https://www.covid19hg.org/ (accessed November 30, 2023).</Citation></Reference><Reference><Citation>Privé F, Arbel J. LDpred2: better, faster, stronger. Bioinformatics. (2020) 36:5424–31. 10.1093/bioinformatics/btaa1029</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa1029</ArticleId><ArticleId IdType="pmc">PMC8016455</ArticleId><ArticleId IdType="pubmed">33326037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo M, Hata J, Ninomiya T, Matsuda K, Yonemoto K, Nakano T, et al. . A nonsynonymous SNP in PRKCH (protein kinase C η) increases the risk of cerebral infarction. Nat Genet. (2007) 39:212–7. 10.1038/ng1945</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1945</ArticleId><ArticleId IdType="pubmed">17206144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Xu G, Zhu W, Cao L, Yan B, Liu X. PRKCH 1425G/A polymorphism predicts recurrence of ischemic stroke in a Chinese population. Mol Neurobiol. (2014) 52:1648–53. 10.1007/s12035-014-8964-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8964-6</ArticleId><ArticleId IdType="pubmed">25370935</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiva-Blanch G, Sala-Vila A, Crespo J, Ros E, Estruch R, Badimon L, et al. . The Mediterranean diet decreases prothrombotic microvesicle release in asymptomatic individuals at high cardiovascular risk. Clin Nutr. (2020) 39:3377–84. 10.1016/j.clnu.2020.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2020.02.027</ArticleId><ArticleId IdType="pubmed">32147198</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, et al. . Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Circulation. (2005) 111:2981–7. 10.1161/CIRCULATIONAHA.104.504340</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.504340</ArticleId><ArticleId IdType="pubmed">15927972</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu G, Gascoigne NRJ. The role of protein kinase Cη in T cell biology. Front Immunol. (2012) 3. 10.3389/fimmu.2012.00177</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00177</ArticleId><ArticleId IdType="pmc">PMC3384082</ArticleId><ArticleId IdType="pubmed">22754555</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu A. The enigmatic protein kinase C-eta. Cancers. (2019) 11. 10.3390/cancers11020214</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers11020214</ArticleId><ArticleId IdType="pmc">PMC6406448</ArticleId><ArticleId IdType="pubmed">30781807</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveh-Amit H, Hai N, Rotem-Dai N, Shahaf G, Gopas J, Livneh E, et al. . Protein kinase Cη activates NF-κB in response to camptothecin-induced DNA damage. Biochem Biophys Res Commun. (2011) 412:313–7. 10.1016/j.bbrc.2011.07.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.07.090</ArticleId><ArticleId IdType="pubmed">21820409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi T, Pigazzini S, Degenhardt F, Cordioli M, Butler-Laporte G, Maya-Miles D, et al. . Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. J Clin Invest. (2021) 131. 10.1172/JCI152386</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI152386</ArticleId><ArticleId IdType="pmc">PMC8631592</ArticleId><ArticleId IdType="pubmed">34597274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Chen ZH, Wang L, Zhang T, Duan L, Behrens C, et al. . LZTFL1 suppresses lung tumorigenesis by maintaining differentiation of lung epithelial cells. Oncogene. (2015) 35:2655–63. 10.1038/onc.2015.328</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/onc.2015.328</ArticleId><ArticleId IdType="pmc">PMC4791215</ArticleId><ArticleId IdType="pubmed">26364604</ArticleId></ArticleIdList></Reference><Reference><Citation>Downes DJ, Cross AR, Hua P, Roberts N, Schwessinger R, Cutler AJ, et al. . Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus. Nat Genet. (2021) 53:1606–15. 10.1038/s41588-021-00955-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00955-3</ArticleId><ArticleId IdType="pmc">PMC7611960</ArticleId><ArticleId IdType="pubmed">34737427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Huang Y, Zhao S, Yao Y, Zhang Y, Qu J, et al. . Integrative genomics analysis reveals a 21q22.11 locus contributing risk to COVID-19. Hum Mol Genet. (2021) 30:1247–58. 10.1093/hmg/ddab125</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddab125</ArticleId><ArticleId IdType="pmc">PMC8136003</ArticleId><ArticleId IdType="pubmed">33949668</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Qiu F, Deng C, Li J, Huang Y, Wu Z, et al. . Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+ monocytes and memory CD8+ T cells involved in severe COVID-19. Genome Med. (2022) 141:16. 10.1101/2022.02.06.21266924</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.06.21266924</ArticleId><ArticleId IdType="pmc">PMC8851814</ArticleId><ArticleId IdType="pubmed">35172892</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>